Israel Englander E Ffector Therapeutics, Inc. Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$0.35 - $1.39 $4,724 - $18,763
13,499 New
13,499 $11,000
Q4 2022

Feb 14, 2023
BUY
$0.38 - $0.66 $1,916 - $3,329
5,044 Added 31.43%
21,091 $9,000
Q3 2022

Nov 14, 2022
BUY
$0.08 - $1.41 $1,283 - $22,626
16,047 New
16,047 $9,000

Others Institutions Holding EFTR

# of Institutions
6
Shares Held
6.53M
Call Options Held
0
Put Options Held
0
View Full List

About eFFECTOR Therapeutics, Inc.

EFTR Quotes by TradingView
  • Ticker EFTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,452,800
  • Description
  • eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-sma...
More about EFTR
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email